David Partrick
Concepts (490)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Wounds, Nonpenetrating | 18 | 2022 | 225 | 2.590 |
Why?
| Thoracoscopy | 8 | 2019 | 53 | 1.780 |
Why?
| Appendicitis | 6 | 2018 | 109 | 1.510 |
Why?
| Laparoscopy | 13 | 2015 | 389 | 1.390 |
Why?
| Myasthenia Gravis | 2 | 2020 | 18 | 1.380 |
Why?
| Spleen | 5 | 2019 | 485 | 1.380 |
Why?
| Trauma Centers | 18 | 2022 | 325 | 1.160 |
Why?
| Multiple Organ Failure | 12 | 2010 | 142 | 1.120 |
Why?
| Funnel Chest | 3 | 2021 | 20 | 1.090 |
Why?
| Appendectomy | 6 | 2018 | 60 | 1.090 |
Why?
| Child | 70 | 2022 | 18366 | 1.020 |
Why?
| Brain Injuries | 6 | 2015 | 452 | 0.950 |
Why?
| Fundoplication | 7 | 2016 | 51 | 0.940 |
Why?
| Length of Stay | 15 | 2019 | 949 | 0.930 |
Why?
| Postoperative Care | 2 | 2016 | 220 | 0.910 |
Why?
| Child, Preschool | 50 | 2021 | 9086 | 0.910 |
Why?
| Retrospective Studies | 51 | 2022 | 12544 | 0.890 |
Why?
| Blood Transfusion | 4 | 2022 | 276 | 0.880 |
Why?
| Forecasting | 3 | 2019 | 333 | 0.780 |
Why?
| Analgesia, Epidural | 1 | 2021 | 20 | 0.770 |
Why?
| Gastroesophageal Reflux | 5 | 2016 | 234 | 0.750 |
Why?
| Empyema | 1 | 2021 | 4 | 0.750 |
Why?
| Nerve Block | 1 | 2021 | 62 | 0.740 |
Why?
| Injury Severity Score | 17 | 2022 | 457 | 0.710 |
Why?
| Gastrostomy | 5 | 2016 | 89 | 0.690 |
Why?
| Thymectomy | 1 | 2019 | 15 | 0.690 |
Why?
| Adolescent | 53 | 2022 | 17829 | 0.690 |
Why?
| Colonic Pouches | 1 | 2019 | 14 | 0.680 |
Why?
| Phlebotomy | 1 | 2019 | 11 | 0.660 |
Why?
| Child Abuse | 6 | 2014 | 450 | 0.660 |
Why?
| Neutrophils | 14 | 2002 | 1164 | 0.650 |
Why?
| Colectomy | 1 | 2019 | 86 | 0.650 |
Why?
| Chest Tubes | 2 | 2019 | 31 | 0.630 |
Why?
| Liver | 4 | 2019 | 1634 | 0.630 |
Why?
| Wounds and Injuries | 10 | 2016 | 723 | 0.620 |
Why?
| Colitis, Ulcerative | 1 | 2019 | 105 | 0.620 |
Why?
| Humans | 114 | 2022 | 114935 | 0.600 |
Why?
| Infant | 32 | 2016 | 7937 | 0.590 |
Why?
| Male | 69 | 2021 | 55663 | 0.590 |
Why?
| Delayed Diagnosis | 2 | 2015 | 71 | 0.580 |
Why?
| Neoplasm Recurrence, Local | 2 | 2022 | 863 | 0.580 |
Why?
| Biopsy | 3 | 2016 | 1045 | 0.580 |
Why?
| Leukocyte Elastase | 7 | 2000 | 79 | 0.570 |
Why?
| Pyloric Stenosis, Hypertrophic | 2 | 2015 | 6 | 0.570 |
Why?
| Female | 70 | 2019 | 59580 | 0.560 |
Why?
| Intubation, Gastrointestinal | 4 | 2015 | 53 | 0.540 |
Why?
| Mediastinal Neoplasms | 2 | 2014 | 32 | 0.540 |
Why?
| Platelet Activating Factor | 6 | 2000 | 87 | 0.530 |
Why?
| Digestive System Surgical Procedures | 3 | 2014 | 90 | 0.520 |
Why?
| Pulmonary Surgical Procedures | 1 | 2015 | 8 | 0.500 |
Why?
| Thoracic Surgery, Video-Assisted | 2 | 2019 | 40 | 0.500 |
Why?
| Postoperative Complications | 10 | 2022 | 2133 | 0.500 |
Why?
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2015 | 14 | 0.490 |
Why?
| Surgery Department, Hospital | 1 | 2015 | 21 | 0.490 |
Why?
| Abdominal Abscess | 2 | 2012 | 24 | 0.490 |
Why?
| Angiography | 2 | 2015 | 176 | 0.490 |
Why?
| Ileal Diseases | 1 | 2014 | 9 | 0.480 |
Why?
| Accidents | 1 | 2014 | 38 | 0.470 |
Why?
| Minimally Invasive Surgical Procedures | 4 | 2014 | 153 | 0.470 |
Why?
| Superoxides | 11 | 2001 | 214 | 0.460 |
Why?
| Embolization, Therapeutic | 2 | 2015 | 177 | 0.460 |
Why?
| Hemoglobins | 5 | 2022 | 314 | 0.440 |
Why?
| Device Removal | 1 | 2014 | 127 | 0.430 |
Why?
| Electroencephalography | 1 | 2015 | 362 | 0.430 |
Why?
| Registries | 8 | 2014 | 1760 | 0.430 |
Why?
| Intensive Care Units, Neonatal | 1 | 2015 | 176 | 0.420 |
Why?
| Anesthesia | 1 | 2014 | 117 | 0.420 |
Why?
| Tomography, X-Ray Computed | 8 | 2021 | 2326 | 0.420 |
Why?
| Abdominal Injuries | 4 | 2015 | 95 | 0.400 |
Why?
| Diagnostic Imaging | 1 | 2014 | 290 | 0.400 |
Why?
| Pancreatic Elastase | 6 | 2001 | 67 | 0.390 |
Why?
| Neutrophil Activation | 4 | 2000 | 94 | 0.380 |
Why?
| Crohn Disease | 1 | 2014 | 196 | 0.380 |
Why?
| Neoplasms | 2 | 2015 | 2106 | 0.370 |
Why?
| Multiple Trauma | 8 | 2005 | 89 | 0.370 |
Why?
| Disease Management | 1 | 2014 | 563 | 0.360 |
Why?
| Ambulatory Surgical Procedures | 1 | 2010 | 48 | 0.350 |
Why?
| Colorado | 18 | 2018 | 4091 | 0.350 |
Why?
| Wounds, Gunshot | 1 | 2013 | 188 | 0.350 |
Why?
| Erythrocyte Transfusion | 3 | 2022 | 186 | 0.340 |
Why?
| Intercellular Adhesion Molecule-1 | 4 | 2001 | 154 | 0.340 |
Why?
| Suture Techniques | 1 | 2010 | 118 | 0.340 |
Why?
| Shock, Hemorrhagic | 3 | 2016 | 193 | 0.330 |
Why?
| Treatment Outcome | 18 | 2016 | 9105 | 0.330 |
Why?
| Craniocerebral Trauma | 4 | 2014 | 128 | 0.320 |
Why?
| Hypotension | 2 | 2016 | 113 | 0.320 |
Why?
| Head Injuries, Closed | 2 | 2011 | 48 | 0.300 |
Why?
| Thoracic Surgical Procedures | 2 | 2005 | 56 | 0.300 |
Why?
| Leukotriene B4 | 2 | 1998 | 48 | 0.300 |
Why?
| Lung | 4 | 2015 | 3593 | 0.300 |
Why?
| Enteral Nutrition | 4 | 2015 | 157 | 0.300 |
Why?
| Laparotomy | 5 | 2015 | 96 | 0.300 |
Why?
| Risk Factors | 15 | 2015 | 8637 | 0.290 |
Why?
| Hemorrhage | 2 | 2016 | 618 | 0.290 |
Why?
| Anti-Bacterial Agents | 2 | 2016 | 1477 | 0.290 |
Why?
| Pain, Postoperative | 2 | 2021 | 191 | 0.280 |
Why?
| Infant, Newborn | 14 | 2016 | 5035 | 0.270 |
Why?
| Endoscopy | 2 | 2007 | 248 | 0.270 |
Why?
| Glasgow Coma Scale | 3 | 2015 | 144 | 0.270 |
Why?
| Sternum | 1 | 2005 | 17 | 0.260 |
Why?
| Severity of Illness Index | 4 | 2016 | 2542 | 0.260 |
Why?
| Mediastinum | 1 | 2005 | 21 | 0.250 |
Why?
| Intraoperative Period | 2 | 2015 | 50 | 0.240 |
Why?
| Hematocrit | 2 | 2015 | 85 | 0.240 |
Why?
| Age Factors | 9 | 2016 | 2891 | 0.230 |
Why?
| Prostheses and Implants | 1 | 2005 | 140 | 0.230 |
Why?
| Triage | 2 | 2014 | 192 | 0.230 |
Why?
| Follow-Up Studies | 8 | 2019 | 4427 | 0.220 |
Why?
| Drainage | 3 | 2019 | 151 | 0.220 |
Why?
| Phospholipases A | 3 | 2001 | 101 | 0.220 |
Why?
| Splenectomy | 3 | 2015 | 51 | 0.210 |
Why?
| Solitary Pulmonary Nodule | 1 | 2002 | 25 | 0.200 |
Why?
| Cardiopulmonary Bypass | 3 | 2003 | 176 | 0.200 |
Why?
| CD18 Antigens | 4 | 2001 | 33 | 0.200 |
Why?
| Macrophage-1 Antigen | 3 | 1998 | 33 | 0.190 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2000 | 278 | 0.190 |
Why?
| Hernias, Diaphragmatic, Congenital | 2 | 2015 | 186 | 0.190 |
Why?
| Pulmonary Blastoma | 1 | 2021 | 8 | 0.190 |
Why?
| Inflammation Mediators | 2 | 2004 | 476 | 0.180 |
Why?
| Ribonuclease III | 1 | 2021 | 34 | 0.180 |
Why?
| Ultrasonography, Interventional | 1 | 2021 | 123 | 0.180 |
Why?
| Thoracic Injuries | 2 | 2005 | 53 | 0.180 |
Why?
| DEAD-box RNA Helicases | 1 | 2021 | 56 | 0.180 |
Why?
| Adult | 23 | 2022 | 30608 | 0.180 |
Why?
| Accidents, Traffic | 3 | 2011 | 167 | 0.180 |
Why?
| Incidence | 7 | 2018 | 2316 | 0.180 |
Why?
| Joint Dislocations | 1 | 2000 | 56 | 0.180 |
Why?
| Neuroblastoma | 2 | 2014 | 132 | 0.170 |
Why?
| Lung Neoplasms | 3 | 2021 | 2223 | 0.170 |
Why?
| Empyema, Pleural | 1 | 2019 | 11 | 0.170 |
Why?
| Proctocolectomy, Restorative | 1 | 2019 | 19 | 0.170 |
Why?
| Cervical Vertebrae | 1 | 2000 | 106 | 0.170 |
Why?
| Hospitals, Pediatric | 4 | 2018 | 479 | 0.170 |
Why?
| Systemic Inflammatory Response Syndrome | 3 | 2010 | 71 | 0.170 |
Why?
| Fibrinolytic Agents | 2 | 2019 | 233 | 0.160 |
Why?
| Blood Loss, Surgical | 1 | 2019 | 85 | 0.160 |
Why?
| Cause of Death | 2 | 2014 | 363 | 0.160 |
Why?
| Endothelial Cells | 2 | 2015 | 685 | 0.160 |
Why?
| Diagnosis, Differential | 4 | 2014 | 1355 | 0.160 |
Why?
| Accidents, Home | 1 | 1998 | 26 | 0.160 |
Why?
| Hernia, Femoral | 1 | 1998 | 2 | 0.160 |
Why?
| Pulmonary Artery | 2 | 2015 | 1028 | 0.150 |
Why?
| Time Factors | 11 | 2014 | 6125 | 0.150 |
Why?
| Prognosis | 7 | 2015 | 3344 | 0.150 |
Why?
| Thoracotomy | 3 | 2019 | 68 | 0.150 |
Why?
| Hernia, Inguinal | 1 | 1998 | 27 | 0.150 |
Why?
| Saline Solution, Hypertonic | 1 | 1998 | 53 | 0.150 |
Why?
| Molsidomine | 1 | 1997 | 5 | 0.150 |
Why?
| Age Distribution | 5 | 2003 | 340 | 0.150 |
Why?
| Young Adult | 6 | 2022 | 10478 | 0.140 |
Why?
| Cyclic GMP | 1 | 1997 | 78 | 0.140 |
Why?
| Kidney | 2 | 2004 | 1184 | 0.140 |
Why?
| Interleukin-8 | 2 | 2003 | 238 | 0.140 |
Why?
| Kidney Neoplasms | 1 | 2021 | 334 | 0.140 |
Why?
| Anesthetics | 1 | 2016 | 54 | 0.140 |
Why?
| Gastrointestinal Agents | 1 | 2016 | 60 | 0.130 |
Why?
| Rectum | 2 | 2010 | 153 | 0.130 |
Why?
| Sex Distribution | 4 | 2002 | 336 | 0.130 |
Why?
| Upper Gastrointestinal Tract | 1 | 2015 | 5 | 0.130 |
Why?
| Recovery of Function | 2 | 2015 | 572 | 0.130 |
Why?
| Injections, Intravenous | 1 | 2016 | 201 | 0.130 |
Why?
| Intestinal Volvulus | 1 | 2015 | 8 | 0.130 |
Why?
| Combined Modality Therapy | 3 | 2016 | 1126 | 0.130 |
Why?
| Shock | 1 | 2016 | 75 | 0.130 |
Why?
| Trauma Severity Indices | 5 | 2013 | 110 | 0.130 |
Why?
| Preoperative Care | 2 | 2015 | 317 | 0.130 |
Why?
| Blood Substitutes | 2 | 2009 | 27 | 0.130 |
Why?
| Interleukin-6 | 3 | 2004 | 676 | 0.130 |
Why?
| Heart Rate | 2 | 2015 | 705 | 0.120 |
Why?
| Rehydration Solutions | 1 | 2014 | 7 | 0.120 |
Why?
| Radiography, Thoracic | 2 | 2014 | 162 | 0.120 |
Why?
| Nitric Oxide | 2 | 2013 | 827 | 0.120 |
Why?
| Isotonic Solutions | 1 | 2014 | 38 | 0.120 |
Why?
| Pneumothorax | 3 | 2021 | 41 | 0.120 |
Why?
| Shock, Traumatic | 1 | 2014 | 16 | 0.120 |
Why?
| Neurilemmoma | 1 | 2014 | 19 | 0.120 |
Why?
| Sentinel Lymph Node Biopsy | 2 | 2005 | 100 | 0.120 |
Why?
| Referral and Consultation | 2 | 2018 | 634 | 0.120 |
Why?
| Child Advocacy | 1 | 2014 | 32 | 0.120 |
Why?
| Hypertension, Pulmonary | 2 | 2016 | 1737 | 0.120 |
Why?
| Specialties, Surgical | 2 | 2014 | 70 | 0.120 |
Why?
| Resuscitation | 3 | 2003 | 247 | 0.110 |
Why?
| Macrophages, Peritoneal | 2 | 2004 | 91 | 0.110 |
Why?
| Clinical Protocols | 1 | 2015 | 232 | 0.110 |
Why?
| Administration, Oral | 1 | 2016 | 731 | 0.110 |
Why?
| Adrenal Gland Neoplasms | 1 | 2014 | 81 | 0.110 |
Why?
| Blood Component Transfusion | 1 | 2014 | 75 | 0.110 |
Why?
| Lymphoma | 1 | 2014 | 177 | 0.110 |
Why?
| Bronchiectasis | 1 | 2014 | 108 | 0.110 |
Why?
| Foreign Bodies | 1 | 2014 | 99 | 0.110 |
Why?
| Stearoyl-CoA Desaturase | 1 | 2013 | 53 | 0.110 |
Why?
| Blood Pressure | 3 | 2015 | 1537 | 0.110 |
Why?
| Bronchi | 1 | 2014 | 243 | 0.110 |
Why?
| Myocytes, Smooth Muscle | 1 | 2015 | 236 | 0.110 |
Why?
| Patient Readmission | 2 | 2016 | 608 | 0.100 |
Why?
| Acidosis | 1 | 2013 | 87 | 0.100 |
Why?
| Neoplasm Metastasis | 1 | 2014 | 530 | 0.100 |
Why?
| Cell Proliferation | 3 | 2015 | 2199 | 0.100 |
Why?
| Survival Rate | 5 | 2014 | 1644 | 0.100 |
Why?
| Carcinoma, Hepatocellular | 1 | 2013 | 213 | 0.100 |
Why?
| Mortality | 1 | 2013 | 288 | 0.090 |
Why?
| Thyroidectomy | 1 | 2011 | 52 | 0.090 |
Why?
| Hematologic Diseases | 1 | 2011 | 57 | 0.090 |
Why?
| Rectal Prolapse | 1 | 2010 | 19 | 0.090 |
Why?
| Prader-Willi Syndrome | 1 | 2010 | 25 | 0.090 |
Why?
| Cardiovascular Agents | 1 | 2011 | 125 | 0.090 |
Why?
| Endocrinology | 1 | 2011 | 69 | 0.090 |
Why?
| Purpura, Thrombocytopenic | 1 | 2010 | 5 | 0.090 |
Why?
| Prospective Studies | 6 | 2006 | 6218 | 0.090 |
Why?
| Coronary Artery Bypass | 2 | 2003 | 198 | 0.090 |
Why?
| Liver Cirrhosis, Biliary | 1 | 2010 | 18 | 0.090 |
Why?
| Perioperative Care | 1 | 2011 | 126 | 0.090 |
Why?
| Patient Discharge | 1 | 2016 | 769 | 0.090 |
Why?
| Analysis of Variance | 4 | 2004 | 1227 | 0.090 |
Why?
| Fat Emulsions, Intravenous | 1 | 2010 | 27 | 0.090 |
Why?
| Platelet Count | 1 | 2010 | 81 | 0.090 |
Why?
| Intestinal Diseases | 1 | 2010 | 33 | 0.090 |
Why?
| Cerebrovascular Circulation | 1 | 2011 | 220 | 0.080 |
Why?
| Lipopolysaccharides | 3 | 2009 | 817 | 0.080 |
Why?
| Risk Assessment | 3 | 2015 | 2975 | 0.080 |
Why?
| General Surgery | 1 | 2011 | 126 | 0.080 |
Why?
| Hernia, Diaphragmatic | 2 | 2013 | 66 | 0.080 |
Why?
| Liver Neoplasms | 1 | 2013 | 509 | 0.080 |
Why?
| Heme Oxygenase-1 | 1 | 2009 | 52 | 0.080 |
Why?
| Parenteral Nutrition | 1 | 2010 | 96 | 0.080 |
Why?
| Fatty Acids, Omega-3 | 1 | 2010 | 122 | 0.080 |
Why?
| Melanoma | 2 | 2005 | 631 | 0.080 |
Why?
| Surgical Wound Infection | 1 | 2011 | 248 | 0.080 |
Why?
| Hirschsprung Disease | 1 | 2010 | 90 | 0.080 |
Why?
| Interleukin-10 | 3 | 2004 | 296 | 0.070 |
Why?
| Skin Neoplasms | 2 | 2005 | 762 | 0.070 |
Why?
| Cellulitis | 1 | 2007 | 45 | 0.070 |
Why?
| NADPH Oxidases | 2 | 1999 | 120 | 0.070 |
Why?
| Pancreatic Neoplasms | 1 | 2014 | 733 | 0.070 |
Why?
| Ultrasonography | 2 | 2003 | 633 | 0.070 |
Why?
| United States | 6 | 2014 | 12211 | 0.070 |
Why?
| Pediatrics | 2 | 2014 | 984 | 0.070 |
Why?
| Acute Lung Injury | 1 | 2010 | 300 | 0.070 |
Why?
| Patient Care Team | 1 | 2011 | 516 | 0.070 |
Why?
| Emergency Medical Services | 1 | 2013 | 587 | 0.070 |
Why?
| Tumor Necrosis Factor-alpha | 4 | 2004 | 1134 | 0.070 |
Why?
| Enzyme Activation | 2 | 2000 | 790 | 0.070 |
Why?
| Viscera | 1 | 2005 | 13 | 0.070 |
Why?
| Mammary Arteries | 1 | 2005 | 6 | 0.070 |
Why?
| Ventriculoperitoneal Shunt | 1 | 2006 | 30 | 0.070 |
Why?
| Pylorus | 1 | 2005 | 11 | 0.060 |
Why?
| Abdominal Pain | 1 | 2006 | 136 | 0.060 |
Why?
| Foreign-Body Migration | 1 | 2005 | 37 | 0.060 |
Why?
| Nevus, Epithelioid and Spindle Cell | 1 | 2005 | 7 | 0.060 |
Why?
| Patient Selection | 2 | 2010 | 642 | 0.060 |
Why?
| Reactive Oxygen Species | 2 | 2015 | 536 | 0.060 |
Why?
| Renal Veins | 1 | 2004 | 9 | 0.060 |
Why?
| Immunity, Innate | 1 | 2010 | 724 | 0.060 |
Why?
| Nevus, Pigmented | 1 | 2005 | 34 | 0.060 |
Why?
| Renal Artery | 1 | 2004 | 25 | 0.060 |
Why?
| Diaphragm | 1 | 2004 | 32 | 0.060 |
Why?
| Predictive Value of Tests | 3 | 2013 | 1801 | 0.060 |
Why?
| Interleukin-11 | 2 | 2003 | 9 | 0.060 |
Why?
| Hernia, Umbilical | 1 | 2003 | 17 | 0.060 |
Why?
| Pleural Effusion | 1 | 2003 | 47 | 0.060 |
Why?
| Cytotoxicity, Immunologic | 2 | 2001 | 196 | 0.060 |
Why?
| Twins, Conjoined | 1 | 2003 | 4 | 0.050 |
Why?
| Stroke | 1 | 2011 | 1019 | 0.050 |
Why?
| Nephrectomy | 1 | 2004 | 149 | 0.050 |
Why?
| Rib Fractures | 1 | 2003 | 24 | 0.050 |
Why?
| Appendix | 1 | 2003 | 26 | 0.050 |
Why?
| Fluoroscopy | 1 | 2003 | 139 | 0.050 |
Why?
| Recurrence | 1 | 2005 | 937 | 0.050 |
Why?
| Tetradecanoylphorbol Acetate | 2 | 1999 | 153 | 0.050 |
Why?
| Anal Canal | 1 | 2003 | 83 | 0.050 |
Why?
| Infant, Premature, Diseases | 1 | 2003 | 89 | 0.050 |
Why?
| Catheterization, Central Venous | 1 | 2003 | 81 | 0.050 |
Why?
| Critical Care | 2 | 2003 | 474 | 0.050 |
Why?
| Diagnostic Errors | 1 | 2003 | 151 | 0.050 |
Why?
| Diseases in Twins | 1 | 2003 | 174 | 0.050 |
Why?
| Pulmonary Edema | 1 | 2002 | 116 | 0.050 |
Why?
| Biopsy, Needle | 1 | 2002 | 183 | 0.050 |
Why?
| Peritonitis | 1 | 2002 | 76 | 0.050 |
Why?
| Sheep | 2 | 2015 | 764 | 0.050 |
Why?
| Myocardial Ischemia | 1 | 2003 | 234 | 0.050 |
Why?
| Middle Aged | 9 | 2014 | 26806 | 0.050 |
Why?
| Abnormalities, Multiple | 1 | 2003 | 177 | 0.050 |
Why?
| Cytokines | 1 | 2009 | 1843 | 0.050 |
Why?
| Decision Support Techniques | 2 | 2015 | 352 | 0.050 |
Why?
| Pyridoxal Phosphate | 1 | 2001 | 20 | 0.050 |
Why?
| Esophageal Achalasia | 1 | 2001 | 25 | 0.050 |
Why?
| Kidney Diseases, Cystic | 1 | 2021 | 21 | 0.050 |
Why?
| Inflammation | 4 | 2001 | 2485 | 0.040 |
Why?
| Germ-Line Mutation | 1 | 2021 | 131 | 0.040 |
Why?
| Hospital Mortality | 2 | 2014 | 776 | 0.040 |
Why?
| CD11 Antigens | 2 | 1998 | 31 | 0.040 |
Why?
| Syndrome | 1 | 2021 | 336 | 0.040 |
Why?
| CHO Cells | 2 | 1998 | 138 | 0.040 |
Why?
| Cricetinae | 2 | 1998 | 254 | 0.040 |
Why?
| Interleukin-1 | 1 | 2004 | 966 | 0.040 |
Why?
| Esophagoscopy | 1 | 2001 | 184 | 0.040 |
Why?
| NF-kappa B | 1 | 2003 | 637 | 0.040 |
Why?
| Sialoglycoproteins | 1 | 1999 | 158 | 0.040 |
Why?
| Antibodies, Monoclonal | 3 | 2010 | 1270 | 0.040 |
Why?
| Logistic Models | 2 | 2015 | 1844 | 0.040 |
Why?
| Morbidity | 2 | 2014 | 277 | 0.040 |
Why?
| Cardiopulmonary Resuscitation | 1 | 2002 | 220 | 0.040 |
Why?
| Odds Ratio | 1 | 2022 | 954 | 0.040 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 1999 | 139 | 0.040 |
Why?
| Signal Transduction | 3 | 2015 | 4524 | 0.040 |
Why?
| Hospitalization | 3 | 2014 | 1754 | 0.040 |
Why?
| Aged | 5 | 2014 | 19122 | 0.040 |
Why?
| Receptors, Interleukin-1 | 1 | 1999 | 227 | 0.040 |
Why?
| Multivariate Analysis | 2 | 2013 | 1440 | 0.040 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 1 | 1999 | 254 | 0.040 |
Why?
| Vas Deferens | 1 | 1998 | 15 | 0.040 |
Why?
| Phosphatidic Acids | 1 | 1998 | 9 | 0.040 |
Why?
| Receptors, Peptide | 1 | 1998 | 18 | 0.040 |
Why?
| Pneumonia | 1 | 2003 | 568 | 0.040 |
Why?
| Animals | 7 | 2015 | 31837 | 0.040 |
Why?
| Heart Arrest | 1 | 2002 | 289 | 0.040 |
Why?
| Blood Bactericidal Activity | 1 | 1998 | 36 | 0.040 |
Why?
| Calcium | 2 | 2001 | 1104 | 0.040 |
Why?
| Myocardium | 1 | 2003 | 911 | 0.040 |
Why?
| Endopeptidases | 1 | 1998 | 72 | 0.040 |
Why?
| Alprostadil | 1 | 1998 | 32 | 0.040 |
Why?
| Osmolar Concentration | 1 | 1998 | 174 | 0.040 |
Why?
| Cell Physiological Phenomena | 1 | 1997 | 23 | 0.040 |
Why?
| Dibutyryl Cyclic GMP | 1 | 1997 | 2 | 0.040 |
Why?
| Transfection | 2 | 1998 | 870 | 0.040 |
Why?
| Respiratory Burst | 1 | 1997 | 28 | 0.040 |
Why?
| Femoral Fractures | 1 | 1998 | 67 | 0.040 |
Why?
| Contrast Media | 2 | 2015 | 353 | 0.040 |
Why?
| Fracture Fixation, Intramedullary | 1 | 1998 | 54 | 0.040 |
Why?
| Cells, Cultured | 4 | 2013 | 3897 | 0.040 |
Why?
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 1997 | 21 | 0.040 |
Why?
| Receptors, Immunologic | 1 | 1998 | 201 | 0.040 |
Why?
| Isoproterenol | 1 | 1997 | 107 | 0.040 |
Why?
| Neoplasm Seeding | 1 | 1996 | 7 | 0.030 |
Why?
| Insufflation | 1 | 1996 | 9 | 0.030 |
Why?
| North Carolina | 1 | 2016 | 97 | 0.030 |
Why?
| Bone Marrow | 1 | 1998 | 245 | 0.030 |
Why?
| Cell Death | 1 | 1998 | 325 | 0.030 |
Why?
| Receptors, Adrenergic, beta | 1 | 1997 | 125 | 0.030 |
Why?
| Substrate Specificity | 1 | 1997 | 354 | 0.030 |
Why?
| Adrenergic beta-Agonists | 1 | 1997 | 126 | 0.030 |
Why?
| Endothelium, Vascular | 3 | 2013 | 848 | 0.030 |
Why?
| Sepsis | 1 | 2002 | 508 | 0.030 |
Why?
| Binding, Competitive | 1 | 1996 | 194 | 0.030 |
Why?
| Radiography | 3 | 2003 | 819 | 0.030 |
Why?
| Awards and Prizes | 1 | 1996 | 56 | 0.030 |
Why?
| Osteosarcoma | 1 | 1996 | 67 | 0.030 |
Why?
| Solubility | 1 | 1996 | 224 | 0.030 |
Why?
| Postoperative Period | 1 | 2016 | 289 | 0.030 |
Why?
| In Vitro Techniques | 1 | 1997 | 1034 | 0.030 |
Why?
| Carbon Dioxide | 1 | 1996 | 218 | 0.030 |
Why?
| Disease Models, Animal | 2 | 2015 | 3549 | 0.030 |
Why?
| Catalase | 1 | 2015 | 117 | 0.030 |
Why?
| Needs Assessment | 1 | 2016 | 315 | 0.030 |
Why?
| Intubation, Intratracheal | 1 | 2016 | 215 | 0.030 |
Why?
| Coculture Techniques | 1 | 2015 | 201 | 0.030 |
Why?
| Disease-Free Survival | 2 | 2006 | 623 | 0.030 |
Why?
| Lymphatic Metastasis | 2 | 2005 | 281 | 0.030 |
Why?
| Craniotomy | 1 | 2014 | 67 | 0.030 |
Why?
| Kinetics | 1 | 1997 | 1555 | 0.030 |
Why?
| Motor Skills | 1 | 2014 | 81 | 0.030 |
Why?
| Fluid Therapy | 1 | 2014 | 122 | 0.030 |
Why?
| Ethanol | 1 | 1998 | 548 | 0.030 |
Why?
| Hep G2 Cells | 1 | 2013 | 61 | 0.030 |
Why?
| Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 54 | 0.030 |
Why?
| Patient Outcome Assessment | 1 | 2014 | 122 | 0.030 |
Why?
| Endothelin-1 | 1 | 2015 | 167 | 0.030 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2013 | 144 | 0.030 |
Why?
| Superoxide Dismutase | 1 | 2015 | 305 | 0.030 |
Why?
| Infant, Premature | 1 | 2016 | 478 | 0.030 |
Why?
| Flow Cytometry | 1 | 1996 | 1087 | 0.030 |
Why?
| RNA, Small Interfering | 1 | 2015 | 543 | 0.030 |
Why?
| Genetic Predisposition to Disease | 1 | 2021 | 2102 | 0.030 |
Why?
| Reoperation | 2 | 2006 | 515 | 0.030 |
Why?
| Neovascularization, Physiologic | 1 | 2013 | 173 | 0.030 |
Why?
| Neoplasm Staging | 2 | 2006 | 1180 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2016 | 1700 | 0.020 |
Why?
| Up-Regulation | 3 | 2001 | 812 | 0.020 |
Why?
| Orthopedic Procedures | 1 | 2014 | 208 | 0.020 |
Why?
| Vertebral Artery | 1 | 2011 | 27 | 0.020 |
Why?
| Carotid Artery Injuries | 1 | 2011 | 43 | 0.020 |
Why?
| Sulfonamides | 1 | 2015 | 445 | 0.020 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 330 | 0.020 |
Why?
| Health Care Costs | 1 | 2014 | 380 | 0.020 |
Why?
| Thyroid Diseases | 1 | 2011 | 30 | 0.020 |
Why?
| Neoplastic Syndromes, Hereditary | 1 | 2011 | 29 | 0.020 |
Why?
| Thyroid Nodule | 1 | 2011 | 38 | 0.020 |
Why?
| Respiration, Artificial | 1 | 2014 | 526 | 0.020 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2013 | 499 | 0.020 |
Why?
| Hospitals, University | 1 | 2011 | 171 | 0.020 |
Why?
| Heparin | 1 | 2011 | 222 | 0.020 |
Why?
| Models, Biological | 1 | 1997 | 1630 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2011 | 387 | 0.020 |
Why?
| Rho(D) Immune Globulin | 1 | 2010 | 3 | 0.020 |
Why?
| Lung Diseases | 1 | 2016 | 703 | 0.020 |
Why?
| Antigens, CD20 | 1 | 2010 | 28 | 0.020 |
Why?
| Cell Line | 2 | 2009 | 2640 | 0.020 |
Why?
| Parenteral Nutrition, Total | 1 | 2010 | 27 | 0.020 |
Why?
| Interdisciplinary Communication | 1 | 2011 | 185 | 0.020 |
Why?
| Survival Analysis | 2 | 2003 | 1220 | 0.020 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 82 | 0.020 |
Why?
| Pancreatic Diseases | 1 | 2010 | 64 | 0.020 |
Why?
| Protoporphyrins | 1 | 2009 | 17 | 0.020 |
Why?
| Medical Oncology | 1 | 2011 | 228 | 0.020 |
Why?
| Enzyme Induction | 1 | 2009 | 84 | 0.020 |
Why?
| Health Care Surveys | 1 | 2011 | 539 | 0.020 |
Why?
| Drug Resistance, Neoplasm | 1 | 2013 | 642 | 0.020 |
Why?
| Steroids | 1 | 2010 | 146 | 0.020 |
Why?
| Rituximab | 1 | 2010 | 151 | 0.020 |
Why?
| Immunoglobulins, Intravenous | 1 | 2010 | 122 | 0.020 |
Why?
| Pain Measurement | 1 | 2011 | 446 | 0.020 |
Why?
| Treatment Failure | 1 | 2010 | 332 | 0.020 |
Why?
| Active Transport, Cell Nucleus | 1 | 2009 | 110 | 0.020 |
Why?
| Transcription Factor RelA | 1 | 2009 | 83 | 0.020 |
Why?
| Cooperative Behavior | 1 | 2011 | 383 | 0.020 |
Why?
| Regression Analysis | 1 | 2011 | 947 | 0.020 |
Why?
| Pancreatectomy | 1 | 2010 | 171 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2015 | 2770 | 0.020 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2011 | 400 | 0.020 |
Why?
| Thyroid Neoplasms | 1 | 2011 | 263 | 0.020 |
Why?
| Radiology | 1 | 2011 | 193 | 0.020 |
Why?
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2010 | 180 | 0.020 |
Why?
| Intestinal Perforation | 1 | 2007 | 38 | 0.020 |
Why?
| Pancreas | 1 | 2010 | 277 | 0.020 |
Why?
| Anticoagulants | 1 | 2011 | 547 | 0.020 |
Why?
| Databases, Factual | 1 | 2011 | 1125 | 0.020 |
Why?
| Cell Nucleus | 1 | 2009 | 554 | 0.020 |
Why?
| Tissue Adhesions | 1 | 2006 | 25 | 0.020 |
Why?
| Cohort Studies | 1 | 2015 | 4903 | 0.020 |
Why?
| Enzyme Inhibitors | 1 | 2009 | 752 | 0.020 |
Why?
| Equipment Failure | 1 | 2006 | 107 | 0.020 |
Why?
| Hospitals, Teaching | 1 | 2005 | 102 | 0.020 |
Why?
| Hydrocephalus | 1 | 2006 | 81 | 0.020 |
Why?
| Hypertension, Renovascular | 1 | 2004 | 11 | 0.010 |
Why?
| Hemothorax | 1 | 2003 | 8 | 0.010 |
Why?
| Subclavian Vein | 1 | 2003 | 13 | 0.010 |
Why?
| Rupture | 1 | 2004 | 95 | 0.010 |
Why?
| Rectovaginal Fistula | 1 | 2003 | 8 | 0.010 |
Why?
| Jugular Veins | 1 | 2003 | 37 | 0.010 |
Why?
| Disease Progression | 1 | 2010 | 2392 | 0.010 |
Why?
| Fetal Death | 1 | 2003 | 49 | 0.010 |
Why?
| E-Selectin | 1 | 2003 | 53 | 0.010 |
Why?
| Infant, Low Birth Weight | 1 | 2003 | 125 | 0.010 |
Why?
| Creatinine | 1 | 2004 | 424 | 0.010 |
Why?
| Monokines | 1 | 2002 | 21 | 0.010 |
Why?
| Chemokine CXCL2 | 1 | 2002 | 37 | 0.010 |
Why?
| Renal Insufficiency | 1 | 2004 | 136 | 0.010 |
Why?
| Zymosan | 1 | 2002 | 63 | 0.010 |
Why?
| Medical Errors | 1 | 2003 | 85 | 0.010 |
Why?
| Safety | 1 | 2004 | 297 | 0.010 |
Why?
| Probability | 1 | 2002 | 291 | 0.010 |
Why?
| Cell Adhesion Molecules | 1 | 2003 | 168 | 0.010 |
Why?
| Leukocyte Count | 1 | 2002 | 292 | 0.010 |
Why?
| Egtazic Acid | 1 | 2001 | 44 | 0.010 |
Why?
| Spine | 1 | 2003 | 136 | 0.010 |
Why?
| Umbilical Veins | 1 | 2001 | 58 | 0.010 |
Why?
| Vagina | 1 | 2003 | 146 | 0.010 |
Why?
| Barium Sulfate | 1 | 2001 | 15 | 0.010 |
Why?
| Chelating Agents | 1 | 2001 | 65 | 0.010 |
Why?
| Manometry | 1 | 2001 | 89 | 0.010 |
Why?
| Cytosol | 1 | 2001 | 208 | 0.010 |
Why?
| Renal Dialysis | 1 | 2004 | 369 | 0.010 |
Why?
| Animals, Newborn | 1 | 2002 | 777 | 0.010 |
Why?
| Prevalence | 1 | 2005 | 2252 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 146 | 0.010 |
Why?
| Spinal Cord Injuries | 1 | 2002 | 173 | 0.010 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 262 | 0.010 |
Why?
| Receptors, Formyl Peptide | 1 | 1998 | 9 | 0.010 |
Why?
| Comorbidity | 1 | 2003 | 1458 | 0.010 |
Why?
| Phospholipases A2 | 1 | 1998 | 76 | 0.010 |
Why?
| Sex Factors | 1 | 2003 | 1721 | 0.010 |
Why?
| Microscopy, Electron | 1 | 1998 | 410 | 0.010 |
Why?
| Colforsin | 1 | 1997 | 44 | 0.010 |
Why?
| Protease Inhibitors | 1 | 1998 | 99 | 0.010 |
Why?
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1997 | 64 | 0.010 |
Why?
| Cross-Linking Reagents | 1 | 1998 | 181 | 0.010 |
Why?
| Alcoholic Intoxication | 1 | 1998 | 62 | 0.010 |
Why?
| Body Weight | 1 | 2001 | 868 | 0.010 |
Why?
| Cell Adhesion | 1 | 1998 | 430 | 0.010 |
Why?
| Reperfusion Injury | 1 | 1997 | 254 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 2004 | 2324 | 0.010 |
Why?
| Down-Regulation | 1 | 1997 | 596 | 0.010 |
Why?
| Trachea | 1 | 1996 | 235 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2005 | 6364 | 0.010 |
Why?
| Rats | 1 | 2002 | 4963 | 0.010 |
Why?
| Adaptation, Physiological | 1 | 1997 | 483 | 0.010 |
Why?
| Mice | 1 | 2009 | 14935 | 0.010 |
Why?
| Biomarkers | 1 | 2003 | 3418 | 0.010 |
Why?
| Emergency Service, Hospital | 1 | 2002 | 1813 | 0.010 |
Why?
| Macrophages | 1 | 1997 | 1266 | 0.010 |
Why?
|
|
Partrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|